[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Alaa Emara\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100557877","suprathel-250-as-a-treatment-for-oropharyngeal-wounds-100557877",false,"NCT06543823","SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds","Der Einsatz Von SUPRATHEL 250 Als Neuartige Therapeutische Option in Oropharyngealen Defekten. \u002F\u002F The Use of SUPRATHEL 250 as a Novel Therapeutic Option for Oropharyngeal Defects","* Indication for tonsillectomy according to the applicable clinical guideline.\n* Male or female patients aged 18 years or older.\n* Ability to understand the study information and provide written informed consent.",true,"ALL","18 Years",{"count":20,"type":21},80,"ESTIMATED","INTERVENTIONAL",[24],"NA","To assess the use of Suprathel 250 for mucosal reconstruction in oropharyngeal defects. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing",[27,28,29],"Tonsillitis","Tonsillectomy","Tonsillitis Recurrent",[31,32,33,28,34],"PLA membrane","Biodegradable membrane","Synthetic","Suprathel","RECRUITING","2026-07-24",{"date":38,"type":39},"2026-07-27","ACTUAL",{"date":41,"type":39},"2025-04-30",{"date":43,"type":21},"2027-04",{"name":45,"class":46},"Alaa Emara","OTHER",""]